Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Six patients with primary biliary cirrhosis (PBC) were treated with a daily oral dose of 600 mg rifampicin for 2 weeks to induce the hepatic metabolism of drugs and bile acids. On rifampicin 5 of 6 patients experienced a pronounced decrease of their pruritus. In all patients the oxidative cytochrome P-450 dependent drug metabolism was induced as shown by an increase of antipyrine-clearance from 36.3 +/- 8.8 to 80.6 +/- 20.1 ml/min and an enhanced urinary excretion of 6-beta-hydroxycortisol from 454 +/- 1.99 to 1607 +/- 362 micrograms/24 h. Furthermore, in all 6 patients the serum alkaline phosphatase declined. In the 3 cholestatic patients (bilirubin greater than 1.0 mg/dl) the serum concentration of total and conjugated bile acids was strikingly reduced. Thus, rifampicin is an inducer of hepatic metabolism in PBC-patients, ameliorates the pruritus and can lower serum concentrations of alkaline phosphatase and bile acids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Clinical Pharmacokinetics of Rifampicin
Acocella, G. (1978) · Clinical Pharmacokinetics · doi:10.2165/00003088-197803020-00002 · Cited by 405
A simple and sensitive assay of total serum bile acids
Mashige, F., Imai, K., & Osuga, T. (1976) · Clinica Chimica Acta · doi:10.1016/0009-8981(76)90007-3 · Cited by 329
Metabolism and Pharmacokinetics of the Antibiotic Rifampin
Kenny, M. T., & Strates, B. S. (1981) · Drug Metabolism Reviews · doi:10.3109/03602538109011084 · Cited by 136
Phenobarbital Effects in Cholestatic Liver Disease
BLOOMER, J. R., & BOYER, J. L. (1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-82-3-310 · Cited by 120 · cited 1×
“Phenobarbital is effective in reducing serum bile acid concentration and pruritus in some patients with chronic cholestatic liver disease, such as primary biliary cirrhosis (PBC), biliary atresia and sclerosing cholangitis (Bloomer and Boyer 1975; Stellard et al. 1979).”
BackgroundDanhof, M., & Breimer, D. D. (1979) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1979.tb01040.x · Cited by 74
Enzyme-inducing drug combinations and their effects on liver microsomal enzyme activity in man
Ohnhaus, E. E., Gerber-Taras, E., & Park, B. K. (1983) · European Journal of Clinical Pharmacology · doi:10.1007/bf00613826 · Cited by 36
Self-citationPhenobarbital-induced alterations of bile acid metabolism in cases of intrahepatic cholestasis
Back, P. (1982) · Journal of Molecular Medicine · doi:10.1007/bf01724209 · Cited by 27
Enzyme induction and renal function in man.
Ohnhaus, E. E., Martin, J. V., Kinser, J. A., & Colombo, J. (1977) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1977.tb00663.x · Cited by 19
Self-citationEffects of rifampin on biliary lipids in humans
von Bergmann, K., Fierer, J., Mok, H. Y. I., & Grundy, S. M. (1981) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.19.2.342 · Cited by 8
Stellaard, F., Bolt, M. G., Jl, B., & Pd, K. (1979) · PubMed · Cited by 6
Cited by
Kaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 1,959
(2011) · Encyclopedia of Cancer · doi:10.1007/978-3-642-16483-5_4730 · Cited by 1,240
Lindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099
Lindor, K. D., Bowlus, C. L., Boyer, J., Levy, C., & Mayo, M. (2019) · Hepatology · doi:10.1002/hep.30145 · Cited by 913
“Rifampicin, a pregnane X receptor agonist, has been used to successfully treat pruritus in patients with PBC in multiple small clinical trials at doses ranging from 150 mg daily to 300 mg twice daily.(193-196) Two meta-analyses have reported that rifampicin administration is associated with relief of pruritus in chole…”
Intrahepatic cholestasis of pregnancy
Geenes, V., & Williamson, C. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.2049 · Cited by 675
Metadata
- Authors
- Hoensch, H. P., Balzer, K., Dylewizc, P., Kirch, W., Goebell, H., & Ohnhaus, E. E.
- Affiliations
- Essen University Hospital (DE)
- ORCID
- Hoensch, H. P.
- Venue
- European Journal of Clinical Pharmacology
- Published
- 1985
- Volume
- 28
- Issue
- 4
- Pages
- 475-477
- ISSN
- 0031-6970 (ISSN-L)
- 1432-1041
- OpenAlex
- W1972626752
- Cited by
- 76
- References
- 10
- Citations by year
- 2024: 2 · 2023: 1 · 2022: 2 · 2021: 1 · 2019: 1 · 2018: 1 · 2016: 1 · 2015: 4 · 2014: 2
- FWCI
- 3.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Journal of Clinical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- rifampicin, primary biliary cirrhosis, drug metabolism induction, cytochrome P450, bile acids, pruritus, antipyrine clearance, alkaline phosphatase, cholestasis, hepatic metabolism
- MeSH terms
- Adult, Alkaline Phosphatase, Antipyrine, Bile Acids and Salts, Humans, Liver, Liver Cirrhosis, Biliary, Middle Aged, Rifampin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis. https://app.cochat.ai/papers/10.1007/bf00544371
- The paper
- Hoensch, H. P., Balzer, K., Dylewizc, P., Kirch, W., Goebell, H., & Ohnhaus, E. E. (1985). Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis. European Journal of Clinical Pharmacology. https://doi.org/10.1007/bf00544371
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.